SG11202105995QA - Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof - Google Patents
Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereofInfo
- Publication number
- SG11202105995QA SG11202105995QA SG11202105995QA SG11202105995QA SG11202105995QA SG 11202105995Q A SG11202105995Q A SG 11202105995QA SG 11202105995Q A SG11202105995Q A SG 11202105995QA SG 11202105995Q A SG11202105995Q A SG 11202105995QA SG 11202105995Q A SG11202105995Q A SG 11202105995QA
- Authority
- SG
- Singapore
- Prior art keywords
- same
- ketoprofen
- compositions
- crystal
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18215336.1A EP3670489A1 (en) | 2018-12-21 | 2018-12-21 | Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof |
PCT/EP2019/025464 WO2020126088A1 (en) | 2018-12-21 | 2019-12-20 | Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202105995QA true SG11202105995QA (en) | 2021-07-29 |
Family
ID=65013486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202105995QA SG11202105995QA (en) | 2018-12-21 | 2019-12-20 | Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof |
Country Status (9)
Country | Link |
---|---|
US (1) | US20220071936A1 (en) |
EP (2) | EP3670489A1 (en) |
CN (1) | CN113195445A (en) |
BR (1) | BR112021011368A2 (en) |
CA (1) | CA3122142A1 (en) |
IL (1) | IL283902A (en) |
MA (1) | MA54504A (en) |
SG (1) | SG11202105995QA (en) |
WO (1) | WO2020126088A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3907214A1 (en) * | 2020-05-04 | 2021-11-10 | Dompe' Farmaceutici S.P.A. | Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1497044A (en) * | 1974-03-07 | 1978-01-05 | Prodotti Antibiotici Spa | Salts of phenyl-alkanoic acids |
IT1104556B (en) * | 1977-05-12 | 1985-10-21 | Medea Res Srl | Salt of lysine with meta-benzoyl-hydratropic acid - used as non-ulcerogenic antiinflammatory, analgesic and anti-agglutinant |
-
2018
- 2018-12-21 EP EP18215336.1A patent/EP3670489A1/en not_active Withdrawn
-
2019
- 2019-12-20 CA CA3122142A patent/CA3122142A1/en active Pending
- 2019-12-20 SG SG11202105995QA patent/SG11202105995QA/en unknown
- 2019-12-20 BR BR112021011368A patent/BR112021011368A2/en unknown
- 2019-12-20 MA MA054504A patent/MA54504A/en unknown
- 2019-12-20 EP EP19820987.6A patent/EP3898569A1/en active Pending
- 2019-12-20 US US17/416,627 patent/US20220071936A1/en active Pending
- 2019-12-20 WO PCT/EP2019/025464 patent/WO2020126088A1/en unknown
- 2019-12-20 CN CN201980084329.1A patent/CN113195445A/en active Pending
-
2021
- 2021-06-10 IL IL283902A patent/IL283902A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3670489A1 (en) | 2020-06-24 |
BR112021011368A2 (en) | 2022-03-03 |
MA54504A (en) | 2022-03-30 |
US20220071936A1 (en) | 2022-03-10 |
IL283902A (en) | 2021-07-29 |
EP3898569A1 (en) | 2021-10-27 |
CA3122142A1 (en) | 2020-06-25 |
WO2020126088A1 (en) | 2020-06-25 |
CN113195445A (en) | 2021-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL256395B (en) | Stabilized anti-microbial compounds, peptides, compositions comprising thereof, and methods of producing the same | |
PL3668937T3 (en) | Compositions and uses of z-1-chloro-2,3,3,3-tetrafluoroprop-1-ene | |
EP3481402A4 (en) | Compounds, compositions, and methods for the treatment of disease | |
EP3510138A4 (en) | Distributed systems for the efficient production and use of microbe-based compositions | |
EP3448875A4 (en) | Compositions for the treatment of disease | |
EP3448987A4 (en) | Compositions for the treatment of disease | |
EP3675859A4 (en) | Compounds, compositions, and methods for the treatment of disease | |
EP3484504A4 (en) | Compounds, compositions, and methods for the treatment of disease | |
IL263709A (en) | Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use | |
WO2016011222A3 (en) | Circular polynucleotides | |
EP3325608A4 (en) | Methods and microorganisms for the production of 1,3-butanediol | |
EP3487482A4 (en) | New cannabis tablet formulations and compositions and methods of making the same | |
WO2015191945A3 (en) | Solid state forms of sofosbuvir | |
EP3694499A4 (en) | Novel process for the preparation of lifitegrast | |
ZA201903928B (en) | Compositions comprising methylphenidate-prodrugs, processes of making and using the same | |
ZA202103498B (en) | Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use | |
WO2015171738A3 (en) | Fragrance compositions | |
EP3728241A4 (en) | Process for the preparation of opicapone and intermediates thereof | |
EP3717456A4 (en) | Process for the preparation of roxadustat and its intermediates | |
IL272451A (en) | Process for the preparation of 1-(3,5-dichlorophenyl)-2,2,2-trifluoroethanone and derivatives thereof | |
EP3538126A4 (en) | Bacteriocin production, compositions and methods of use | |
EP3497077A4 (en) | Amide compounds, pharmaceutical compositions thereof, and methods of using the same | |
ZA201803250B (en) | New 5-azido-5-deoxy-2 :3-isopropylidene-d-arabinose compounds; their method of manufacture and their use for the synthesis of ara-n3, kdo-n3 and 4ekdo-n3 | |
IL283902A (en) | Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof | |
GB201604126D0 (en) | A novel form of amicarbazone, a process for its preparation and use of the same |